# ENTA (Enanta Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Enanta Pharmaceuticals, Inc. reported $63.00M in revenue and a net loss of $68.25M for the fiscal year ended September 30, 2026 (down 3.6% year over year), with a -99.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/ENTA
- Markdown: https://convexityos.com/fundamentals/ENTA.md
- SEC CIK: 0001177648
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:39 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001177648&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2026 | $63.00M | -3.6% YoY |
| Operating Income | FY 2026 | -$62.38M | -99.0% margin |
| Net Income | FY 2026 | -$68.25M | -108.3% net margin |
| Diluted EPS | FY 2026 | -$2.35 | Split-adjusted |
| Free Cash Flow | FY 2026 | -$42.77M | -67.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $194.5M | Total debt: $54.76M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $63.00M | $65.32M | $67.64M | $79.20M | $86.16M | $97.07M | $122.5M | $205.2M | $206.6M | $102.8M |
| Research & Development | $88.55M | $106.7M | $131.5M | $163.5M | $164.5M | $174.1M | $136.8M | $142.2M | $94.86M | $57.45M |
| **Operating Income** | -$62.38M | -$85.35M | -$121.7M | -$137.2M | -$123.8M | -$109.6M | -$41.64M | $36.74M | $88.33M | $24.61M |
| **EBITDA** | -$57.60M | -$80.76M | -$119.4M | -$134.8M | -$120.9M | -$106.2M | -$37.99M | $40.00M | $90.85M | $26.75M |
| Interest Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $2.53M |
| Interest Expense | $14.07M | $7.68M | $10.94M | $5.15M | $0 | $0 | -- | -- | -- | $40K |
| Income Before Tax | -$68.21M | -$83.55M | -$117.8M | -$131.0M | -$122.2M | -$107.6M | -$35.02M | $45.56M | $93.12M | $26.95M |
| Income Tax Expense | $40K | -$1.66M | -$1.74M | $2.82M | -$433K | -$28.58M | $1.15M | -$826K | $21.16M | $9.24M |
| **Net Income** | -$68.25M | -$81.89M | -$116.0M | -$133.8M | -$121.8M | -$79.00M | -$36.17M | $46.38M | $71.96M | $17.71M |
| Basic EPS | -$2.35 | -$3.84 | -$5.48 | -$6.38 | -$5.91 | -$3.92 | -$1.81 | $2.37 | $3.74 | $0.93 |
| **Diluted EPS** | -$2.35 | -$3.84 | -$5.48 | -$6.38 | -$5.91 | -$3.92 | -$1.81 | $2.21 | $3.48 | $0.91 |
| Basic Shares Outstanding | 29.0M | 21.3M | 21.2M | 21.0K | 20.6K | 20.2K | 19.9K | 19.6M | 19.3M | 19.1M |
| Diluted Shares Outstanding | 29.0M | 21.3M | 21.2M | 21.0K | 20.6K | 20.2K | 19.9K | 21.0M | 20.6M | 19.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $12.87M | $14.36M | $17.16M | $18.61M | $15.12M | $18.31M | $14.93M | $16.96M |
| Research & Development | $26.12M | $22.13M | $19.44M | $20.86M | $23.81M | $27.21M | $28.07M | $27.66M |
| **Operating Income** | -$22.04M | -$17.24M | -$11.85M | -$11.25M | -$18.39M | -$18.89M | -$24.53M | -$23.54M |
| **EBITDA** | -$20.88M | -$16.05M | -$10.64M | -$10.02M | -$17.10M | -$17.68M | -$23.32M | -$22.65M |
| Interest Expense | $3.54M | $4.13M | $3.32M | $3.08M | $2.39M | $1.62M | $1.71M | $1.96M |
| Income Before Tax | -$23.75M | -$19.46M | -$13.08M | -$11.91M | -$18.67M | -$18.23M | -$23.95M | -$22.71M |
| Income Tax Expense | -$27K | $36K | $7.0K | $24K | $32K | $29K | -$1.30M | -$416K |
| **Net Income** | -$23.72M | -$19.50M | -$13.09M | -$11.94M | -$18.70M | -$18.25M | -$22.64M | -$22.29M |
| Basic EPS | -- | -$0.67 | -$0.45 | -$0.42 | -- | -$0.85 | -$1.06 | -$1.05 |
| **Diluted EPS** | -- | -$0.67 | -$0.45 | -$0.42 | -- | -$0.85 | -$1.06 | -$1.05 |
| Basic Shares Outstanding | -- | 29.1M | 29.0M | 28.7M | -- | 21.4M | 21.4M | 21.2M |
| Diluted Shares Outstanding | -- | 29.1M | 29.0M | 28.7M | -- | 21.4M | 21.4M | 21.2M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $20.27M | $32.30M | $37.23M | $85.39M | $43.99M | $57.21M | $87.13M | $51.23M | $63.90M | $65.67M |
| Short-Term Investments | $174.2M | $156.6M | $211.0M | $284.5M | $205.2M | $186.8M | $299.5M | $284.0M | $244.8M | $158.0M |
| **Cash & Short-Term Investments** | $194.5M | $188.9M | $248.2M | $369.9M | $249.2M | $244.0M | $386.6M | $335.2M | $308.7M | $223.7M |
| Accounts Receivable, Net | $5.86M | $6.88M | $6.65M | $8.61M | $20.32M | $23.58M | $23.49M | $51.31M | $67.20M | $10.61M |
| **Total Current Assets** | $206.0M | $204.3M | $299.9M | $422.8M | $311.7M | $319.0M | $436.8M | $401.8M | $380.4M | $237.8M |
| Property, Plant & Equipment, Net | $30.86M | $35.40M | $32.69M | $11.92M | $6.17M | $5.94M | $8.60M | $10.93M | $8.37M | $8.05M |
| Long-Term Investments | -- | $0 | -- | $0 | $29.29M | $108.4M | $32.63M | $65.01M | $16.39M | $70.04M |
| Other Non-Current Assets | $116K | $92K | $94K | $803K | $696K | $92K | $92K | $92K | $92K | -- |
| **Total Non-Current Assets** | $69.58M | $76.40M | $76.80M | $39.48M | $63.70M | $119.8M | $49.30M | $87.98M | $33.84M | $88.82M |
| **Total Assets** | $275.6M | $280.7M | $376.7M | $462.3M | $375.4M | $438.8M | $486.1M | $489.8M | $414.2M | $326.6M |
| Accounts Payable | $2.75M | $1.95M | $8.00M | $4.10M | $6.00M | $9.54M | $5.74M | $6.69M | $4.75M | $3.71M |
| **Total Current Liabilities** | $54.46M | $48.55M | $57.53M | $62.79M | $29.83M | $36.17M | $24.16M | $22.61M | $16.02M | $20.98M |
| Other Non-Current Liabilities | $295K | $260K | $231K | $663K | $454K | $558K | $1.08M | $3.10M | $2.90M | $2.41M |
| **Total Non-Current Liabilities** | $140.9M | $167.5M | $190.3M | $182.8M | $24.25M | $3.19M | $6.39M | $4.73M | $4.52M | $3.98M |
| **Total Liabilities** | $195.4M | $216.0M | $247.8M | $245.5M | $54.08M | $39.36M | $30.55M | $27.34M | $20.55M | $24.96M |
| **Total Debt (incl. Leases)** | $54.76M | $57.90M | $55.47M | $26.51M | $25.26M | $5.33M | $8.10M | -- | -- | -- |
| Common Stock | $291K | $214K | $212K | $211K | $208K | $202K | $201K | $197K | $194K | $191K |
| Retained Earnings | -$473.2M | -$404.9M | -$323.0M | -$207.0M | -$73.18M | $48.58M | $127.6M | $163.7M | $117.4M | $45.36M |
| Accumulated Other Comp. Income | -$983K | -$339K | $302K | -$1.17M | -$3.72M | -$382K | $844K | $146K | -$398K | -$112K |
| **Total Stockholders' Equity** | $80.19M | $64.72M | $128.8M | $216.7M | $321.3M | $399.4M | $455.6M | $462.5M | $393.7M | $301.7M |
| Total Equity | $80.19M | $64.72M | $128.8M | $216.7M | $321.3M | $399.4M | $455.6M | $462.5M | $393.7M | $301.7M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $20.27M | $33.42M | $34.93M | $37.44M | $32.30M | $44.81M | $60.21M | $84.35M |
| Short-Term Investments | $174.2M | $156.1M | $128.8M | $148.4M | $156.6M | $159.3M | $133.2M | $132.3M |
| **Cash & Short-Term Investments** | $194.5M | $189.5M | $163.8M | $185.8M | $188.9M | $204.1M | $193.4M | $216.7M |
| Accounts Receivable, Net | $5.86M | $6.53M | $7.81M | $8.49M | $6.88M | $8.33M | $6.79M | $7.72M |
| **Total Current Assets** | $206.0M | $203.6M | $178.4M | $198.7M | $204.3M | $222.7M | $242.9M | $268.1M |
| Property, Plant & Equipment, Net | $30.86M | $31.94M | $33.11M | $34.31M | $35.40M | $36.62M | $37.57M | $37.37M |
| Long-Term Investments | -- | $21.99M | $63.24M | $56.05M | $0 | -- | -- | -- |
| Other Non-Current Assets | $116K | $110K | $144K | $93K | $92K | $94K | $98K | $94K |
| **Total Non-Current Assets** | $69.58M | $93.25M | $136.3M | $130.8M | $76.40M | $78.32M | $80.13M | $80.50M |
| **Total Assets** | $275.6M | $296.9M | $314.7M | $329.5M | $280.7M | $301.0M | $323.0M | $348.6M |
| Accounts Payable | $2.75M | $3.29M | $4.36M | $1.89M | $1.95M | $3.55M | $4.76M | $4.73M |
| **Total Current Liabilities** | $54.46M | $54.17M | $46.44M | $44.73M | $48.55M | $44.55M | $45.95M | $49.05M |
| Other Non-Current Liabilities | $295K | $286K | $278K | $269K | $260K | $252K | $243K | $235K |
| **Total Non-Current Liabilities** | $140.9M | $141.6M | $151.7M | $158.2M | $167.5M | $177.2M | $183.5M | $187.8M |
| **Total Liabilities** | $195.4M | $195.8M | $198.1M | $202.9M | $216.0M | $221.8M | $229.5M | $236.8M |
| **Total Debt (incl. Leases)** | $54.76M | $55.66M | $56.54M | $57.07M | $57.90M | $58.05M | $58.73M | $57.46M |
| Common Stock | $291K | $291K | $291K | $290K | $214K | $214K | $214K | $213K |
| Retained Earnings | -$473.2M | -$449.5M | -$430.0M | -$416.9M | -$404.9M | -$386.2M | -$368.0M | -$345.3M |
| Accumulated Other Comp. Income | -$983K | -$927K | -$734K | -$329K | -$339K | -$402K | -$224K | -$29K |
| **Total Stockholders' Equity** | $80.19M | $101.1M | $116.6M | $126.6M | $64.72M | $79.28M | $93.54M | $111.8M |
| Total Equity | $80.19M | $101.1M | $116.6M | $126.6M | $64.72M | $79.28M | $93.54M | $111.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$68.25M | -$81.89M | -$116.0M | -$133.8M | -$121.8M | -$79.00M | -$36.17M | $46.38M | $71.96M | $17.71M |
| Depreciation & Amortization | $4.78M | $4.59M | $2.34M | $2.37M | $2.97M | $3.33M | $3.64M | $3.26M | $2.52M | $2.14M |
| Stock-Based Compensation | $14.03M | $18.57M | $26.80M | $28.22M | $26.97M | $20.99M | $19.57M | $19.23M | $15.85M | $13.07M |
| Change in Receivables | $1.03M | -$236K | $1.97M | $11.70M | $3.26M | -$84K | $27.82M | $15.89M | -$56.59M | $2.23M |
| Change in Payables | $763K | -$1.31M | -$414K | -$1.15M | -$4.63M | $3.77M | -$883K | $1.79M | $1.32M | $633K |
| **Operating Cash Flow** | -$42.56M | -$19.27M | -$78.76M | -$103.2M | -$84.78M | -$70.00M | $7.09M | $71.42M | $29.22M | $52.65M |
| Capital Expenditure | -$206K | -$12.90M | -$17.95M | -$9.06M | -$2.12M | -$750K | -$1.45M | -$5.42M | -$2.98M | -$2.51M |
| **Free Cash Flow** | -$42.77M | -$32.17M | -$96.71M | -$112.2M | -$86.91M | -$70.75M | $5.64M | $66.00M | $26.24M | $50.15M |
| Purchases of Investments | -$231.9M | -$209.6M | -$307.3M | -$373.4M | -$171.4M | -$307.3M | -$338.6M | -$549.3M | -$293.1M | -$251.4M |
| **Investing Cash Flow** | -$17.18M | $40.35M | $58.23M | -$53.58M | $54.90M | $36.99M | $19.83M | -$86.66M | -$35.40M | -$4.57M |
| Common Stock Issued | -- | -- | -- | -- | -- | $3.61M | $10.48M | $6.85M | $6.24M | $1.08M |
| **Financing Cash Flow** | $47.72M | -$26.62M | -$27.63M | $198.1M | $20.03M | $3.08M | $8.98M | $2.57M | $4.41M | $1.02M |
| **Net Change in Cash** | -$12.03M | -$5.54M | -$48.16M | $41.39M | -$9.85M | -$29.93M | $35.90M | -$12.67M | -$1.77M | $49.10M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$23.72M | -$19.50M | -$13.09M | -$11.94M | -$18.70M | -$18.25M | -$22.64M | -$22.29M |
| Depreciation & Amortization | $1.16M | $1.19M | $1.21M | $1.23M | $1.28M | $1.21M | $1.20M | $889K |
| Stock-Based Compensation | $2.79M | $3.68M | $3.75M | $3.81M | $4.03M | $4.18M | $4.69M | $5.67M |
| Change in Receivables | $679K | $1.27M | $684K | -$1.61M | $1.45M | -$1.54M | $926K | -$1.07M |
| Change in Payables | -$576K | -$1.08M | $2.48M | -$63K | -$723K | -$1.29M | $873K | -$168K |
| **Operating Cash Flow** | -$13.73M | -$9.97M | -$7.16M | -$11.70M | -$6.49M | $17.51M | -$13.49M | -$16.80M |
| Capital Expenditure | -$41K | -$7.0K | -$15K | -$143K | -$1.46M | -$155K | -$2.54M | -$8.74M |
| **Free Cash Flow** | -$13.77M | -$9.98M | -$7.17M | -$11.84M | -$7.95M | $17.35M | -$16.03M | -$25.55M |
| Purchases of Investments | -$15.79M | -$25.51M | -$41.95M | -$148.6M | -$68.62M | -$85.99M | -$55.02M | $0 |
| **Investing Cash Flow** | $4.17M | $14.01M | $11.94M | -$47.30M | $2.30M | -$26.48M | -$4.37M | $68.90M |
| **Financing Cash Flow** | -$3.58M | -$5.54M | -$7.29M | $64.14M | -$8.32M | -$6.42M | -$6.89M | -$4.99M |
| **Net Change in Cash** | -$13.15M | -$1.51M | -$2.51M | $5.14M | -$12.51M | -$15.40M | -$24.74M | $47.12M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -99.0% | -130.7% | -179.9% | -173.2% | -143.7% | -112.9% | -34.0% | 17.9% | 42.7% | 23.9% |
| **Net Profit Margin** | -108.3% | -125.4% | -171.6% | -169.0% | -141.3% | -81.4% | -29.5% | 22.6% | 34.8% | 17.2% |
| Return on Equity (ROE) | -85.1% | -126.5% | -90.1% | -61.7% | -37.9% | -19.8% | -7.9% | 10.0% | 18.3% | 5.9% |
| Return on Assets (ROA) | -24.8% | -29.2% | -30.8% | -28.9% | -32.4% | -18.0% | -7.4% | 9.5% | 17.4% | 5.4% |
| Current Ratio | 3.78x | 4.21x | 5.21x | 6.73x | 10.45x | 8.82x | 18.08x | 17.77x | 23.74x | 11.33x |
| Quick Ratio | 3.68x | 4.03x | 4.43x | 6.03x | 9.04x | 7.40x | 16.98x | 17.10x | 23.46x | 11.17x |
| Debt to Equity | 0.68x | 0.89x | 0.43x | 0.12x | 0.08x | 0.01x | 0.02x | -- | -- | -- |
| **Revenue Growth (YoY)** | -3.6% | -3.4% | -14.6% | -8.1% | -11.2% | -20.7% | -40.3% | -0.7% | +101.0% | +16.5% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -213.3% | -58.4% | +258.9% | -20.2% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -178.0% | -35.5% | +306.3% | -18.3% |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -176.4% | -36.6% | +302.2% | -18.4% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -1087.5% | -90.1% | +144.4% | -44.5% | +47.0% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -1353.7% | -91.5% | +151.5% | -47.7% | +61.4% |
| 5Y Revenue / Share Growth | -100.0% | -100.0% | -69.5% | +35099.0% | +77450.1% | +103104.8% | +71189.8% | -99.6% | +227.7% | -85.9% |
| 10Y Revenue / Share Growth | -53.4% | -64.5% | -99.9% | +115244.4% | +10817.4% | +12761.0% | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -- | -331.6% | -170868.1% | -636305.4% | -342257.9% | -42977.6% | -99.9% | +280.0% | -95.3% |
| 10Y Net Income / Share Growth | -305.6% | -190.7% | -100.3% | -648936.2% | -30168.0% | -18904.5% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -99.0% | -90.0% | -87.2% | -109.1% | -130.7% | -149.4% | -158.4% | -165.7% |
| **Net Profit Margin** | -108.3% | -96.9% | -89.6% | -106.8% | -125.4% | -142.0% | -149.6% | -157.6% |
| Return on Equity (ROE) | -85.1% | -62.6% | -53.2% | -56.5% | -126.5% | -116.1% | -103.1% | -93.8% |
| Return on Assets (ROA) | -24.8% | -21.3% | -19.7% | -21.7% | -29.2% | -30.6% | -29.9% | -30.1% |
| Current Ratio | 3.78x | 3.76x | 3.84x | 4.44x | 4.21x | 5.00x | 5.29x | 5.47x |
| Quick Ratio | 3.68x | 3.62x | 3.69x | 4.34x | 4.03x | 4.77x | 4.36x | 4.58x |
| Debt to Equity | 0.68x | 0.55x | 0.48x | 0.45x | 0.89x | 0.73x | 0.63x | 0.51x |
| **Revenue Growth (YoY)** | -14.9% | -21.6% | +15.0% | +9.8% | +3.5% | +1.9% | -12.5% | -5.8% |
| Operating Cash Flow Growth (YoY) | -- | -157.0% | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -157.5% | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
